FINAL BILL REPORT

2SHB 2681

This analysis was prepared by non-partisan legislative staff for the use of legislative members in their deliberations. This analysis is not a part of the legislation nor does it constitute a statement of legislative intent.

Background:

A pharmacist is a person licensed by the Pharmacy Quality Assurance Commission to engage in the practice of pharmacy. The practice of pharmacy includes the initiation or modification of drug therapy in accordance with written guidelines or protocols previously established and approved for his or her practice by a practitioner authorized to prescribe drugs. The written guideline or protocol, also known as a collaborative drug therapy agreement, is an agreement in which any practitioner authorized to prescribe legend drugs delegates to a pharmacist or group of pharmacists authority to conduct specified prescribing functions. The agreement must include:

the parties subject to the agreement—the practitioner authorized to prescribe must be in active practice, and the authority granted must be within the scope of the practitioners' current practice;
a time period not to exceed two years during which the written guidelines or protocol will be in effect; and
the type of prescriptive authority decisions which the pharmacist or pharmacists are authorized to make.

Summary:

To increase awareness of the availability of contraceptives in pharmacies, the Pharmacy Quality Assurance Commission must develop a sticker or sign to be displayed on the window or door of a pharmacy that initiates or modifies drug therapy related to self-administered contraception.

Votes on Final Passage:

House	67	30
Senate	46	3	(Senate amended)
House	92	4	(House concurred)